Skip to main content
EVE HEALTH GROUP LIMITED. logo

EVE HEALTH GROUP LIMITED. — Investor Relations & Filings

Ticker · EVE ISIN · AU000000EVE3 ASX Manufacturing
Open in API
Filings indexed 950 across all filing types
Latest filing 2026-05-21 Director's Dealing
Country AU Australia
Listing ASX EVE

About EVE HEALTH GROUP LIMITED.

https://www.evehealthgroup.com.au

EVE Health Group Limited is a health and wellness company focused on the production and distribution of natural and organic products derived from native botanicals. The company operates through its subsidiaries, primarily Meluka Australia and Jenbrook. Its core activities involve the cultivation of organic tea tree and the production of premium honey products, including bio-active and probiotic-infused varieties. EVE Health Group emphasizes sustainable farming practices and the development of health-focused consumer goods, such as essential oils, botanical beverages, and functional foods. The company targets global markets, leveraging the medicinal properties of its raw materials to provide high-quality wellness solutions.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 205.7KB
Director's Dealing Classification · 96% confidence The document is an ASX Appendix 3Y “Change of Director’s Interest Notice” detailing the direct and indirect interests, acquisitions, and disposals of securities by a company director. This is a report of personal share transactions by a director, matching the "Director's Dealing" category.
2026-05-21 English
Results of Meeting 2 pages 178.2KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Results of General Meeting' and details the outcomes of shareholder votes at a General Meeting held on 8 May 2026. It includes specific voting results for multiple resolutions, indicating the number and percentage of votes for, against, and abstained. The content focuses on the official announcement of voting results rather than the meeting materials or the meeting itself. The document length is 3852 characters, which is relatively short and consistent with a voting results announcement. Therefore, this document fits the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2026-05-07 English
Application for quotation of securities - EVE 7 pages 20.8KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue dates, and related information about securities issued as part of previously announced transactions. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement related to capital markets and securities listing. This fits the category of Share Issue/Capital Change announcements, as it concerns the issuance and quotation of new shares and options.
2026-05-07 English
Change of Director's Interest Notice 2 pages 208.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including direct and indirect interests, number of shares acquired, disposed, and held, and the nature of the transactions. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document is not an annual report, earnings release, or any other financial report but specifically a notification of director's share transactions.
2026-05-07 English
Notification regarding unquoted securities - EVE 8 pages 25.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted options by EVE Health Group Limited. It includes specifics such as the number of securities issued, exercise prices, expiry dates, and references to previous announcements (Appendix 3B). The content focuses on the issuance of new securities and their terms, which aligns with announcements related to share issues or capital changes. There is no indication that this is a full financial report, audit, earnings release, or management discussion. The document is a formal notification of new securities issued, fitting the category of Share Issue/Capital Change rather than a report or announcement of a report publication. Therefore, the appropriate classification is 'SHA' (Share Issue/Capital Change). The document length (8340 characters) supports it being a full notification rather than a brief announcement or certification.
2026-05-07 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 319.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'March 2026 Quarterly Update' and includes detailed operational, commercial, and financial information for the quarter ended 31 March 2026. It contains a comprehensive cash flow statement (Appendix 4C), details on capital raising, appointments, and financial position, including cash flows from operating, investing, and financing activities. The presence of substantive financial data and analysis for a quarter, along with the quarterly cash flow report, indicates this is a quarterly financial report. The document is about 15,000 characters long, which is substantial and contains the actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2026
2026-04-28 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.